Lituania -
Lituavi -
SMCA (Valstybinė vaistų kontrolės tarnyba)
injekcinis vanduo sanitas
pharmaswiss Česká republika s.r.o. - injekcinis vanduo - tirpiklis parenteriniam vartojimui - 5 ml - solvents and diluting agents, incl. irrigating solutions
Uni Eropa -
Lituavi -
EMA (European Medicines Agency)
prialt
esteve pharmaceuticals gmbh - zikonotidas - injections, spinal; pain - analgetikai - zikonotidas skiriamas sunkiam, lėtiniam skausmui gydyti pacientams, kuriems reikalinga intratekalio (it) analgezija.
Lituania -
Lituavi -
SMCA (Valstybinė vaistų kontrolės tarnyba)
extra
delaval nv, industriepark-drongen 10, 9031 gent, belgija. - natrio hipochloritas, kuriame yra ... aktyvaus chloro - veikliosios medžiagos cas nr.: 7681-52-9, eb nr.: 231-668-3, veikliosios medžiagos pavadinimas: natrio hipochloritas, kuriame yra ... aktyvaus chloro, koncentracija: 4.8% , veiklioji
Lituania -
Lituavi -
SMCA (Valstybinė vaistų kontrolės tarnyba)
dexamethasone kalceks
as kalceks - deksametazono natrio fosfatas - injekcinis ar infuzinis tirpalas - 4 mg/ml - dexamethasone
Lituania -
Lituavi -
SMCA (Valstybinė vaistų kontrolės tarnyba)
gammanorm
octapharma (ip) sprl - Žmogaus normalusis imunoglobulinas - injekcinis tirpalas - 165 mg/ml - immunoglobulins, normal human, for extravascular adm.
Uni Eropa -
Lituavi -
EMA (European Medicines Agency)
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcinos - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. naudoti šios vakcinos turėtų būti laikantis oficialių rekomendacijų.
Lituania -
Lituavi -
SMCA (Valstybinė vaistų kontrolės tarnyba)
septanest
septodont - artikaino hidrochloridas/adrenalinas - injekcinis tirpalas - 40 mg/5 µg/ml - articaine, combinations
Lituania -
Lituavi -
SMCA (Valstybinė vaistų kontrolės tarnyba)
septanest forte
septodont - artikaino hidrochloridas/adrenalinas - injekcinis tirpalas - 40 mg/10 µg/ml - articaine, combinations
Lituania -
Lituavi -
SMCA (Valstybinė vaistų kontrolės tarnyba)
bupivacaine accord
accord healthcare b.v. - bupivakainas - injekcinis tirpalas - 2,5 mg/ml; 5 mg/ml - bupivacaine